Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 12-2017 | 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -812 | -391 | 112,300 | N/A | 170,500 |
| Depreciation Amortization | 10 | N/A | 254,800 | N/A | 235,600 |
| Income taxes - deferred | N/A | N/A | -600 | N/A | 2,400 |
| Accounts receivable | N/A | N/A | -27,700 | N/A | 0 |
| Accounts payable and accrued liabilities | N/A | N/A | 31,100 | N/A | -38,300 |
| Other Working Capital | 76 | N/A | -46,400 | N/A | -67,400 |
| Other Operating Activity | 0 | 0 | 86,400 | 0 | 107,700 |
| Operating Cash Flow | $-727 | $-391 | $409,900 | $N/A | $410,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118 | N/A | -234,300 | N/A | -213,500 |
| Net Acquisitions | N/A | N/A | -183,500 | N/A | -13,700 |
| Sale Of Investment | N/A | N/A | 10,300 | N/A | 3,600 |
| Other Investing Activity | 0 | 0 | -3,100 | 0 | 0 |
| Investing Cash Flow | $-118 | $N/A | $-410,600 | $N/A | $-223,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 988 | 481 | 1,103,700 | N/A | 1,914,600 |
| Debt Issued | N/A | N/A | -23,500 | N/A | -21,700 |
| Dividend Paid | N/A | N/A | -138,900 | N/A | -138,900 |
| Other Financing Activity | 0 | 0 | -958,300 | 0 | -1,914,000 |
| Financing Cash Flow | $988 | $481 | $-17,000 | $N/A | $-160,000 |
| Beginning Cash Position | 243 | 153 | 246,500 | N/A | 219,600 |
| End Cash Position | 387 | 243 | 228,800 | N/A | 246,500 |
| Net Cash Flow | $144 | $90 | $-17,700 | $N/A | $26,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -727 | -391 | 409,900 | N/A | 410,500 |
| Capital Expenditure | -118 | N/A | -250,400 | N/A | -214,900 |
| Free Cash Flow | -844 | -391 | 159,500 | 0 | 195,600 |